Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Glioblastoma and MDM2[original query] |
---|
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain pathology (Zurich, Switzerland) 2009 Apr 19 (2): 188-94. Zawlik Izabela, Kita Daisuke, Vaccarella Salvatore, Mittelbronn Michel, Franceschi Silvia, Ohgaki Hiro |
The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme. Journal of neurosurgery 2008 Nov 109 (5): 842-8. Khatri Rina G, Navaratne Kapila, Weil Robert |
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (21): 6683-93. Felsberg Jörg, Rapp Marion, Loeser Simon, Fimmers Rolf, Stummer Walter, Goeppert Matthias, Steiger Hans-Jacob, Friedensdorf Britta, Reifenberger Guido, Sabel Michael |
Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. American journal of clinical pathology 2009 Feb 131 (2): 257-63. Ruano Yolanda, Ribalta Teresa, de Lope Angel Rodríguez, Campos-Martín Yolanda, Fiaño Concepción, Pérez-Magán Elisa, Hernández-Moneo José-Luis, Mollejo Manuela, Meléndez Bárba |
Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Neuropathology : official journal of the Japanese Society of Neuropathology 2010 1 30 (4): 392-400. Benito Rafael, Gil-Benso Rosario, Quilis Vicente, Perez Miguel, Gregori-Romero Mariela, Roldan Pedro, Gonzalez-Darder Jose, Cerdá-Nicolas Miguel, Lopez-Gines Conc |
Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16. Life sciences 2019 4 225 55-63. Wei Yuzhen, Wang Fang, Sang Ben, Xu Zhen, Yang Dong |
Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma. Neoplasia (New York, N.Y.) 2020 11 22 (12): 800-808. Stasik Sebastian, Juratli Tareq A, Petzold Andreas, Richter Sven, Zolal Amir, Schackert Gabriele, Dahl Andreas, Krex Dietmar, Thiede Christi |
The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study. Current oncology (Toronto, Ont.) 2021 Mar 28 (2): 1280-1293. Kalita Ondrej, Sporikova Zuzana, Hajduch Marian, Megova Houdova Magdalena, Slavkovsky Rastislav, Hrabalek Lumir, Halaj Matej, Klementova Yvona, Dolezel Martin, Drabek Jiri, Tuckova Lucie, Ehrmann Jiri, Vrbkova Jana, Trojanec Radek, Vaverka Mirosl |
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
Polymorphisms in TPT1 Pathways in Pediatric Astrocytomas. ASN neuro 2023 1 15 17590914231153481. Morais de Castro Eduardo, Barbosa Leonardo Vinícius, Simoneti Fonseca Aline, Nagashima Seigo, Busatta Vaz de Paula Caroline, Zeni Rafaela, Panini do Carmo Letícia Arianne, Cavalli Luciane R, Bleggi Torres Luiz Fernando, Senff Ribeiro Andrea, de Noronha Lucia, Machado-Souza Cleb |
- Page last reviewed:Feb 1, 2024
- Content source: